Skip to main content
    D

    DR Horton Inc (DHI)

    Official site

    CONSUMER CYCLICAL • RESIDENTIAL CONSTRUCTION • NYSE

    $144.79
    -0.76 (-0.52%)

    Market Cap: $39.51B

    Last updated: Nov 17, 2026 at 11:04 AM ET

    DR Horton Inc (DHI) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    DR Horton (DHI) trades at 14.3x trailing earnings and 1.2x sales. Its P/E of 14.3x is above its 5-year median of 9.7x. Its forward P/E is 18.4x. The median P/E across 10 similar companies is 12.6x.

    Current Multiples

    Its forward P/E is above its trailing P/E, which implies earnings per share about 22.3% lower over the next year. Its free cash flow yield is 7.8%.

    MultipleValue
    P/E (trailing)14.3x
    Forward P/E18.4x
    Price to sales1.2x
    Price to book1.7x
    EV/EBITDA10.9x
    Price to FCF12.8x
    EV/FCF14.3x
    PEG1.8
    FCF yield7.8%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/E is 30.0% above 11.0x, its P/S is in line and its P/B is 10.5% below 1.9x.

    MultipleCurrent5-year median10-year median
    P/E14.3x9.7x11.0x
    P/S1.2x1.2x1.2x
    P/B1.7x1.8x1.9x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/E ranged from 5.5x in 2022 to 19.1x in 2017.

    Year endPriceP/EP/SP/B
    2025$144.0313.1x1.3x1.8x
    2024$139.829.9x1.2x1.8x
    2023$151.9810.9x1.4x2.2x
    2022$89.145.5x0.9x1.5x
    2021$108.458.6x1.4x2.5x
    2020$68.929.5x1.0x2.0x
    2019$52.7511.4x1.4x1.9x
    2018$34.668.5x0.8x1.4x
    2017$51.0719.1x1.3x2.4x
    2016$27.3311.0x0.8x1.5x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About DHI

    What is DHI's forward P/E ratio?

    DR Horton has a forward P/E ratio of 18.4x.

    Is DHI stock overvalued?

    GNG's valuation label for DHI is Fairly valued. Its P/E of 14.3x compares with a median of 12.6x across 10 similar companies.

    What is DHI's price to sales ratio?

    DR Horton has a price to sales ratio of 1.2x.

    What is DR Horton's average P/E ratio over 5 years?

    DR Horton's median P/E over the last 5 years is 9.7x, from 60 month-end values through Oct 2026.

    What is DHI's PEG ratio?

    DR Horton has a PEG ratio of 1.8.